call for abstracts
Welcome to the EUCROF25 Call for Abstracts.
The EUCROF24 conference saw over 300 attendees from across Europe and beyond come together in Prague to discuss the latest and future challenges and opportunities in clinical research. EUCROF24 was the 7th running of The European Clinical Research Conference. Prior to 2024 the Conference ran every two years. Following the overwhelming success of EUCROF24 we are delighted to announce that the Conference will now take place annually.
EUCROF25 will take place in Copenhagen from 2-4 February next year. EUCROF25 will feature plenary sessions and panel discussions as well as a series of 5 breakout streams running through the two main days.
The Call for Abstracts to speak at EUCROF25 is now open. This Call for Abstracts invites you to send in your abstract to be considered for an oral presentation at EUCROF25. Irrespective of whether you are a subject matter expert or a person concerned (e.g., patient), your presentation will add value to our Conference and, vice versa, you will take home valuable information from our Conference. Please submit your abstract by 30th June 2024 using the form which you can access from the button below.
We are looking forward to hearing from you and to meeting you at the next EUCROF Conference in February 2025 in Copenhagen.
Suggested Topics (this is only for guidance and we will accept abstracts covering other topic areas)
EU Clinical Trials Regulation – Experiences from different Stakeholder
- Authorities
- Sponsors
- Commercial
- Non-commercial
- Investigational Sites
- Ethics Committees
- Protection of personal data and commercially confidential information
- Other
Outsourcing clinical trials in Europe
- Trends
- Models
- Challenges and opportunities
- Attractiveness of European clinical research to overseas sponsors
- Making Europe more appealing
Operational Aspects
- Supply chain/product supply
- Cross-functional efficiencies
- Partnerships
Initiatives to ensure innovation for the benefit of patients
- ACT EU – Accelerating Clinical Trials in the European Union
- EU pharma legislation revision
- Other
ICH Considerations
- ICH-GCP actual status of:
- Annex 1
- Annex 2
- The use of Real World Data in Clinical Trials
- Acceptance by authorities?
- GDPR aspects
- ICH M11: Clinical Electronic Structured Harmonised Protocol (CESHARP)
- Other ICH Initiatives/Topics
Patient / Patient Representative Involvement
- Trial Design
- Mobile Apps
- Tele Medicine
- Trial Results
- Other topics on patient (representative) involvement
Decentralised Elements of Clinical Trials
- Electronic Signature
- Electronic Health Records
- eConsent Process
- Provision of IMP
- Home Visits
- Quality Management
- Other Aspects
Digitisation and remote processes
- eTMF – where are we?
- Remote Inspections
- Wearables and Source Data
- Dynamic Archiving
- Artificial Intelligence in Clinical Development
- Other
Accepted Abstracts
If your abstract is accepted for an oral presentation you will be invited to speak at EUCROF25. In this circumstance you will be offered the following:
Free daytime attendance on the day you speak
OR
25% reduction on the full conference package price (which includes 2 day attendance, accommodation & conference dinner)
Permission
In submitting the abstract you confirm that you have the approval (if required) from your employer to attend and present this material at EUCROF25.
